Don’t miss the latest developments in business and finance.

Glenmark Pharmaceuticals gets tentative approval for Dronedarone Tablets, 400 mg

Image
Capital Market
Last Updated : Jan 06 2016 | 7:50 PM IST

From USFDA

Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the United States Food & Drug Administration for its Dronedarone Tablets, 400 mg, the generic version of Multaq Tablets, 400 mg of Sanofi- Aventis U.S., LLC.

Powered by Capital Market - Live News

Also Read

First Published: Jan 06 2016 | 10:27 AM IST

Next Story